Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The latest update of “Global Ovarian Cancer Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Ovarian Cancer Market.
Overview of the Ovarian Cancer Market:
Ovarian cancer is one of the most frequently diagnosed cancers among women. The ovaries, a pair of molars, are usually the site where menstrual blood (lactated) is absorbed. In nearly all cases, ovarian cancer happens after the age of 40, and in most instances, it takes place after the age of 60. The most common type of ovarian cancer starts in epithelial cells, which are the flat, smooth cells that line most surfaces and most cavities in the human body. When these cells begin to grow abnormally - extending out of their places, enlarging in some areas, or spreading to other parts of the body - they become potential cancers.
The growing prevalence of ovarian cancer is a key factor driving the market growth of ovarian cancer drugs. According to the World Cancer Research Fund International, ovarian cancer is the 18th most common cancer worldwide. There were nearly 300,000 new cases in 2018. Increasing focus of manufacturers in developing novel therapeutics that are efficient and cost-effective is again contributing to market growth. Growing geriatric population as ovarian cancer is more prevalent among elderly women is expected to positively impact the market growth. Also, the growing development of chemotherapies for the management of ovarian cancer is further expected to foster market growth.
From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of cancer in the region coupled with the growing research and development for producing efficient therapies. According to the National Cancer Institute, around 1.2 percent of women will be diagnosed with ovarian cancer at some point during their lifetime. In 2017, there were an estimated 233,364 women living with ovarian cancer in the United States.
Key Developments:
- In April 2020, the Food and Drug Administration approved niraparib (ZEJULA, GlaxoSmithKline) for the treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
- In May 2020, AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) in combination with bevacizumab has been approved in the US for the treatment of adult patients with an advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
- In July 2020, Cadila Pharmaceuticals announced the launch of Bevasizumab biosimilar for the domestic market. Bevacizumab biosimilar is a humanized monoclonal antibody, recommended in multiple indications and will be launched under the brand name Bevaro.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Ovarian Cancer Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Ovarian Cancer Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Bristol Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline plc
- Janssen Pharmaceuticals, Inc.
- Novogen, Inc.
- Genentech Inc.
- Aetera Zenteris Inc.
- Boehringer Ingelheim GmbH
- F. Hoffman-La Roche Ltd.
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Ovarian Cancer Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Epithelial Tumors
- Germ Cell Tumors
- Stromal Tumors
By Applications, the market is segmented into:
- Hospitals
- Diagnostic Centers
- Drug Stores
- Online Pharmacies
- Other End Users
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ovarian Cancer Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Ovarian Cancer Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Ovarian Cancer Market
1.6.1 How the Covid-19 is Affecting the Ovarian Cancer Market
1.6.1.1 Ovarian Cancer Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Ovarian Cancer Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Ovarian Cancer Market Perspective (2015-2028)
2.2 Ovarian Cancer Market Growth Trends by Regions
2.2.1 Ovarian Cancer Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Ovarian Cancer Market Historic Market Share by Regions (2015-2021)
2.2.3 Ovarian Cancer Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Ovarian Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Ovarian Cancer Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cancer Market Players by Market Size
3.1.1 Global Top Ovarian Cancer Market Players by Revenue (2015-2021)
3.1.2 Global Ovarian Cancer Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ovarian Cancer Market Concentration Ratio
3.2.1 Global Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Market Revenue in 2019
3.3 Ovarian Cancer Market Key Players Head office and Area Served
3.4 Key Players Ovarian Cancer Market Product Solution and Service
3.5 Date of entering into Ovarian Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Ovarian Cancer Market Historic Market Size by Type (2015-2021)
4.2 Global Ovarian Cancer Market Forecasted Market Size by Type (2021-2028)
5 Ovarian Cancer Market Breakdown Data by Application (2015-2028)
5.1 Global Ovarian Cancer Market Size by Application (2015-2021)
5.2 Global Ovarian Cancer Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Ovarian Cancer Market Size (2015-2021)
6.2 Ovarian Cancer Market Key Players in North America (2019-2021)
6.3 North America Ovarian Cancer Market Size by Type (2015-2021)
6.4 North America Ovarian Cancer Market Size by Application (2015-2021)
7 Europe
7.1 Europe Ovarian Cancer Market Size (2015-2021)
7.2 Ovarian Cancer Market Key Players in Europe (2019-2021)
7.3 Europe Ovarian Cancer Market Size by Type (2015-2021)
7.4 Europe Ovarian Cancer Market Size by Application (2015-2021)
8 China
8.1 China Ovarian Cancer Market Size (2015-2021)
8.2 Ovarian Cancer Market Key Players in China (2019-2021)
8.3 China Ovarian Cancer Market Size by Type (2015-2021)
8.4 China Ovarian Cancer Market Size by Application (2015-2021)
9 Japan
9.1 Japan Ovarian Cancer Market Size (2015-2021)
9.2 Ovarian Cancer Market Key Players in Japan (2019-2021)
9.3 Japan Ovarian Cancer Market Size by Type (2015-2021)
9.4 Japan Ovarian Cancer Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Ovarian Cancer Market Size (2015-2021)
10.2 Ovarian Cancer Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Ovarian Cancer Market Size by Type (2015-2021)
10.4 Southeast Asia Ovarian Cancer Market Size by Application (2015-2021)
11 India
11.1 India Ovarian Cancer Market Size (2015-2021)
11.2 Ovarian Cancer Market Key Players in India (2019-2021)
11.3 India Ovarian Cancer Market Size by Type (2015-2021)
11.4 India Ovarian Cancer Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Ovarian Cancer Market Size (2015-2021)
12.2 Ovarian Cancer Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Ovarian Cancer Market Size by Type (2015-2021)
12.4 Central & South America Ovarian Cancer Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Ovarian Cancer Market Introduction
13.4 Ovarian Cancer Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Ovarian Cancer Market Key Market Segments
Table 2. Key Players Covered: Ranking by Ovarian Cancer Market Revenue
Table 3. Ranking of Global Top Ovarian Cancer Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Ovarian Cancer Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Ovarian Cancer Market Players to Combat Covid-19 Impact
Table 10. Global Ovarian Cancer Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Ovarian Cancer Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Ovarian Cancer Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Ovarian Cancer Market Share by Regions (2015-2021)
Table 14. Global Ovarian Cancer Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Ovarian Cancer Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Ovarian Cancer Market Growth Strategy
Table 20. Main Points Interviewed from Key Ovarian Cancer Market Players
Table 21. Global Ovarian Cancer Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Ovarian Cancer Market Share by Players (2015-2021)
Table 23. Global Top Ovarian Cancer Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer Market as of 2019)
Table 24. Global Ovarian Cancer Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Ovarian Cancer Market Product Solution and Service
Table 27. Date of entering into Ovarian Cancer Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 30. Global Ovarian Cancer Market Size Share by Type (2015-2021)
Table 31. Global Ovarian Cancer Market Revenue Market Share by Type (2021-2028)
Table 31. Global Ovarian Cancer Market Size Share by Application (2015-2021)
Table 33. Global Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 34. Global Ovarian Cancer Market Size Share by Application (2021-2028)
Table 35. North America Key Players Ovarian Cancer Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Ovarian Cancer Market Share (2019-2021)
Table 37. North America Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 38. North America Ovarian Cancer Market Share by Type (2015-2021)
Table 39. North America Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 40. North America Ovarian Cancer Market Share by Application (2015-2021)
Table 41. Europe Key Players Ovarian Cancer Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Ovarian Cancer Market Share (2019-2021)
Table 43. Europe Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Ovarian Cancer Market Share by Type (2015-2021)
Table 45. Europe Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Ovarian Cancer Market Share by Application (2015-2021)
Table 47. China Key Players Ovarian Cancer Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Ovarian Cancer Market Share (2019-2021)
Table 49. China Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 50. China Ovarian Cancer Market Share by Type (2015-2021)
Table 51. China Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 52. China Ovarian Cancer Market Share by Application (2015-2021)
Table 53. Japan Key Players Ovarian Cancer Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Ovarian Cancer Market Share (2019-2021)
Table 55. Japan Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Ovarian Cancer Market Share by Type (2015-2021)
Table 57. Japan Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Ovarian Cancer Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Ovarian Cancer Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Ovarian Cancer Market Share (2019-2021)
Table 61. Southeast Asia Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Ovarian Cancer Market Share by Type (2015-2021)
Table 63. Southeast Asia Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Ovarian Cancer Market Share by Application (2015-2021)
Table 65. India Key Players Ovarian Cancer Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Ovarian Cancer Market Share (2019-2021)
Table 67. India Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 68. India Ovarian Cancer Market Share by Type (2015-2021)
Table 69. India Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 70. India Ovarian Cancer Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Ovarian Cancer Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Ovarian Cancer Market Share (2019-2021)
Table 73. Central & South America Ovarian Cancer Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Ovarian Cancer Market Share by Type (2015-2021)
Table 75. Central & South America Ovarian Cancer Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Ovarian Cancer Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Ovarian Cancer Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Ovarian Cancer Market Share by Type: 2021 VS 2028
Figure 2. Global Ovarian Cancer Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Ovarian Cancer Market Report Years Considered
Figure 8. Global Ovarian Cancer Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Ovarian Cancer Market Share by Regions: 2021 VS 2028
Figure 10. Global Ovarian Cancer Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Ovarian Cancer Market Share by Players in 2019
Figure 13. Global Top Ovarian Cancer Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Ovarian Cancer Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Ovarian Cancer Market Revenue in 2019
Figure 15. North America Ovarian Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Ovarian Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Ovarian Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Ovarian Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Ovarian Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Ovarian Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Ovarian Cancer Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
